ESLOY
Price
$147.70
Change
+$0.57 (+0.39%)
Updated
Aug 8 closing price
Capitalization
136.16B
66 days until earnings call
TRUMY
Price
$18.60
Change
-$0.07 (-0.37%)
Updated
Aug 8 closing price
Capitalization
27.47B
87 days until earnings call
Interact to see
Advertisement

ESLOY vs TRUMY

Header iconESLOY vs TRUMY Comparison
Open Charts ESLOY vs TRUMYBanner chart's image
EssilorLuxottica
Price$147.70
Change+$0.57 (+0.39%)
Volume$25.11K
Capitalization136.16B
Terumo
Price$18.60
Change-$0.07 (-0.37%)
Volume$158.26K
Capitalization27.47B
ESLOY vs TRUMY Comparison Chart in %
Loading...
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ESLOY vs. TRUMY commentary
Aug 12, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ESLOY is a StrongBuy and TRUMY is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Aug 12, 2025
Stock price -- (ESLOY: $147.70 vs. TRUMY: $18.60)
Brand notoriety: ESLOY and TRUMY are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ESLOY: 47% vs. TRUMY: 61%
Market capitalization -- ESLOY: $136.16B vs. TRUMY: $27.47B
ESLOY [@Pharmaceuticals: Other] is valued at $136.16B. TRUMY’s [@Pharmaceuticals: Other] market capitalization is $27.47B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $168.51B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $10.79B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ESLOY’s FA Score shows that 3 FA rating(s) are green whileTRUMY’s FA Score has 0 green FA rating(s).

  • ESLOY’s FA Score: 3 green, 2 red.
  • TRUMY’s FA Score: 0 green, 5 red.
According to our system of comparison, ESLOY is a better buy in the long-term than TRUMY.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ESLOY’s TA Score shows that 5 TA indicator(s) are bullish while TRUMY’s TA Score has 4 bullish TA indicator(s).

  • ESLOY’s TA Score: 5 bullish, 5 bearish.
  • TRUMY’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, ESLOY is a better buy in the short-term than TRUMY.

Price Growth

ESLOY (@Pharmaceuticals: Other) experienced а -0.05% price change this week, while TRUMY (@Pharmaceuticals: Other) price change was +9.41% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.86%. For the same industry, the average monthly price growth was -3.35%, and the average quarterly price growth was +2.88%.

Reported Earning Dates

ESLOY is expected to report earnings on Oct 16, 2025.

TRUMY is expected to report earnings on Nov 06, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+1.86% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ESLOY($136B) has a higher market cap than TRUMY($27.5B). ESLOY has higher P/E ratio than TRUMY: ESLOY (49.19) vs TRUMY (34.66). ESLOY YTD gains are higher at: 26.487 vs. TRUMY (-4.615). TRUMY has higher annual earnings (EBITDA): 247B vs. ESLOY (6.71B). TRUMY has more cash in the bank: 195B vs. ESLOY (3.16B). ESLOY has less debt than TRUMY: ESLOY (14B) vs TRUMY (175B). TRUMY has higher revenues than ESLOY: TRUMY (987B) vs ESLOY (27.2B).
ESLOYTRUMYESLOY / TRUMY
Capitalization136B27.5B495%
EBITDA6.71B247B3%
Gain YTD26.487-4.615-574%
P/E Ratio49.1934.66142%
Revenue27.2B987B3%
Total Cash3.16B195B2%
Total Debt14B175B8%
FUNDAMENTALS RATINGS
ESLOY vs TRUMY: Fundamental Ratings
ESLOY
TRUMY
OUTLOOK RATING
1..100
5750
VALUATION
overvalued / fair valued / undervalued
1..100
33
Fair valued
38
Fair valued
PROFIT vs RISK RATING
1..100
1697
SMR RATING
1..100
9599
PRICE GROWTH RATING
1..100
4851
P/E GROWTH RATING
1..100
3240
SEASONALITY SCORE
1..100
n/a14

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

ESLOY's Valuation (33) in the null industry is in the same range as TRUMY (38). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOY's Profit vs Risk Rating (16) in the null industry is significantly better than the same rating for TRUMY (97). This means that ESLOY’s stock grew significantly faster than TRUMY’s over the last 12 months.

ESLOY's SMR Rating (95) in the null industry is in the same range as TRUMY (99). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOY's Price Growth Rating (48) in the null industry is in the same range as TRUMY (51). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

ESLOY's P/E Growth Rating (32) in the null industry is in the same range as TRUMY (40). This means that ESLOY’s stock grew similarly to TRUMY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ESLOYTRUMY
RSI
ODDS (%)
Bearish Trend 4 days ago
60%
Bearish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
47%
Bearish Trend 4 days ago
65%
Momentum
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
71%
MACD
ODDS (%)
Bearish Trend 4 days ago
54%
Bullish Trend 4 days ago
64%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
51%
Bullish Trend 4 days ago
66%
TrendMonth
ODDS (%)
Bearish Trend 4 days ago
47%
Bullish Trend 4 days ago
65%
Advances
ODDS (%)
Bullish Trend 4 days ago
58%
Bullish Trend 5 days ago
67%
Declines
ODDS (%)
Bearish Trend 6 days ago
50%
Bearish Trend 12 days ago
63%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
41%
Bearish Trend 4 days ago
74%
Aroon
ODDS (%)
Bullish Trend 4 days ago
50%
Bearish Trend 4 days ago
64%
View a ticker or compare two or three
Interact to see
Advertisement
ESLOY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TRUMY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DRCT0.420.02
+4.14%
Direct Digital Holdings
MYGN6.320.22
+3.61%
Myriad Genetics
DGX176.962.69
+1.54%
Quest Diagnostics
CWT46.78-0.10
-0.21%
California Water Service
SVCO4.01-0.15
-3.61%
Silvaco Group Inc

ESLOY and

Correlation & Price change

A.I.dvisor indicates that over the last year, ESLOY has been loosely correlated with ESLOF. These tickers have moved in lockstep 58% of the time. This A.I.-generated data suggests there is some statistical probability that if ESLOY jumps, then ESLOF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ESLOY
1D Price
Change %
ESLOY100%
+0.39%
ESLOF - ESLOY
58%
Loosely correlated
+0.21%
SMMNY - ESLOY
41%
Loosely correlated
+0.82%
SAUHY - ESLOY
37%
Loosely correlated
-1.11%
CLPBY - ESLOY
33%
Poorly correlated
-1.05%
LZAGY - ESLOY
32%
Poorly correlated
-1.21%
More

TRUMY and

Correlation & Price change

A.I.dvisor indicates that over the last year, TRUMY has been loosely correlated with HOCPY. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if TRUMY jumps, then HOCPY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TRUMY
1D Price
Change %
TRUMY100%
-0.37%
HOCPY - TRUMY
51%
Loosely correlated
+4.52%
SSMXY - TRUMY
46%
Loosely correlated
+0.80%
OLYMY - TRUMY
44%
Loosely correlated
-1.32%
GNNDY - TRUMY
33%
Poorly correlated
+4.33%
ESLOY - TRUMY
30%
Poorly correlated
+0.39%
More